Advertisement
Research Article

Respiratory Syncytial Virus Interferon Antagonist NS1 Protein Suppresses and Skews the Human T Lymphocyte Response

  • Shirin Munir,

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Philippa Hillyer,

    Affiliation: Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Maryland, United States of America

    X
  • Cyril Le Nouën,

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Ursula J. Buchholz,

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Ronald L. Rabin,

    Affiliation: Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Maryland, United States of America

    X
  • Peter L. Collins,

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Alexander Bukreyev mail

    alexander.bukreyev@utmb.edu

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    Current address: Galveston National Laboratory, Center for Biodefense and Emerging Infectious Diseases, Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America

    X
  • Published: April 21, 2011
  • DOI: 10.1371/journal.ppat.1001336

Reader Comments (0)

Post a new comment on this article